Webinars and Videos

SPC case law update

In this webinar European patent attorney Garreth Duncan discusses important 2019 SPC-related developments starting with the long-running litigation between Gilead Sciences and a number of generics companies on SPCs for combination drugs, followed by two CJEU cases (C-650/17 and C-114/18) relating to how specifically an approved drug should be described and claimed in the basic patent in order to qualify for SPC protection, third party SPCs (C-239/19) obtained by applicants without the consent of the marketing authorisation (MA) holder, as well as and SPCs and Brexit.

Patent newsletter Latest edition
Patent newsletter Latest edition
Patent Book EPO Board of Appeal Decisions
Patent Book EPO Board of Appeal Decisions